NNOX trade ideas
I am upgrading my $NNOX Target from $115 to $200+I seen what happened at $95, the FDA response, and how people responded to lockup expiration + the secondary offering. People reacted quickly, things got tense, and now the storm will soon calm. The point is, it very recently hit a new high, and a new high will happen likely really soon. Once $115 passes, my new target is $200. I believe this is feasible if single source FDA approval is within a timely manner. They also have factories and deployments. I am looking constantly at institutional activity, and that is what excites me the most trend-wise. That said, please invest at your own risk and do your own due diligence. Everything I say is on an opinion based basis.
US Stock In Play: $NNOX (Nano-X Imaging Ltd.)With Wall Street’s attention fully focused on the exasperation and parabolic price behavior of $GME, $BB, $BBNY and $AMC this week, $NNOX have slipped under the media radar with a +65% rally since Friday, breaking out of its consolidated price action within a Symmetrical Triangle chart pattern. $NNOX closed at $85.13, posting a new all-time high for the first time since December 2020.
$NNOX price rally with coupled with infusion of significant liquidity, where trading volume returns to a level that was last witnessed in November 2020. Current price volatility have surge to a day range of $7.13, barely a dollar away from its peak volatility established in September 2020.
$NNOX - 5-month Ascending Triangle Opportunity (Pre-Breakout)$NNOX had an explosive upside move on Friday.
An upside breakout of this ascending triangle gives me the following targets:
TG1: 76.50
TG2: 86
TG3: 96.50
Invalidation under: 52.19
Leave some feedback below if you have any!
And don't forget to like and follow if you'd like more 👍
$NNOX, Wait for the Catalyst + Short Squeeze (Low Volume)Nanox has been shortened alot, and now oversold on low volume. Looking at the RSI, it is quite low, and due for a breakout. Outside of this, I believe it has been announced that they have pre-orders for within the range of 15k machines. This accounts to what could be $1 billion in mostly revenue, if I understand currently from what has been said about the JP Morgan Virtual Conference. At the current market cap of $2.3B, this puts them likely under their fair overall enterprise value. Currently, FDA approval is a major catalyst that should be "soon" in regards to single source if everything goes well. Multi-source could be in the first half of 2021. It is currently a waiting game in regards to catalyst. There are also other big catalyst such as a factory announcement that may happen soon. Regarding patterns, I think overall a bullish setup is there. Currently, I am long. That said, do your own due diligence and invest at your own risk.